Dexrazoxane Intravenous and Pneumococcal Conjugate Vaccine (13-Valent)
Determining the interaction of Dexrazoxane Intravenous and Pneumococcal Conjugate Vaccine (13-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Pneumococcal Conjugate Vaccine (7-Valent)
- Dexrazoxane Intravenous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Dexrazoxane Intravenous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Dexrazoxane Intravenous-Pneumovax 23
- Dexrazoxane Intravenous-PNV - Omega
- Dexrazoxane Intravenous-PNV Iron Polysaccharides, Folic Acid, DHA
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextenza Insert
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextenza intraocular
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextran 40
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextran 70 6% in 5% Dextrose high molecular weight
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextran 75
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextran high molecular weight